A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
Academic Article
Publication Date:
2019
Iris type:
1.1 Articolo in rivista
Keywords:
5-ASA; IBD98-M; inflammatory bowel disease; mesalamine; mesalazine; sodium hyaluronate; ulcerative colitis; Adult; Capsules; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Endoscopy; Female; Humans; Male; Mesalamine; Middle Aged; Placebos; Remission Induction; Sulfasalazine; Treatment Outcome
List of contributors:
Fiorino, Gionata; Sturniolo, Giacomo Carlo; Bossa, Fabrizio; Cassinotti, Andrea; di Sabatino, Antonio; Giuffrida, Paolo; Danese, Silvio
Published in: